Page last updated: 2024-09-05

sb 203580 and Diabetic Glomerulosclerosis

sb 203580 has been researched along with Diabetic Glomerulosclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, H; Huang, J; Huang, K; Lan, T; Liu, P; Liu, W; Peng, J; Shen, X; Xie, X	1

Other Studies

1 other study(ies) available for sb 203580 and Diabetic Glomerulosclerosis

Article	Year
S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition. Experimental cell research, 2012, May-01, Volume: 318, Issue:8 Topics: Animals; Diabetic Nephropathies; Extracellular Matrix; Extracellular Signal-Regulated MAP Kinases; Fibronectins; Flavonoids; Glucose; Hyperglycemia; Imidazoles; Kidney; Lysophospholipids; MAP Kinase Signaling System; Mesangial Cells; p38 Mitogen-Activated Protein Kinases; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; RNA Interference; RNA, Messenger; RNA, Small Interfering; Sphingosine; Sphingosine-1-Phosphate Receptors	2012

Article

Year

S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition.

Experimental cell research, 2012, May-01, Volume: 318, Issue:8

Topics: Animals; Diabetic Nephropathies; Extracellular Matrix; Extracellular Signal-Regulated MAP Kinases; Fibronectins; Flavonoids; Glucose; Hyperglycemia; Imidazoles; Kidney; Lysophospholipids; MAP Kinase Signaling System; Mesangial Cells; p38 Mitogen-Activated Protein Kinases; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; RNA Interference; RNA, Messenger; RNA, Small Interfering; Sphingosine; Sphingosine-1-Phosphate Receptors

2012